Kuano closes £1.8M seed funding round to validate quantum simulation platform for drug discovery

Kuano, a drug discovery company combining quantum mechanics with AI to design the next generation of medicines, today announced the close of its £1.8M seed funding round, led by Mercia Ventures, and including ACF Investors, Ascension Ventures, o2h Ventures, Meltwind Advisory LLP, and other Angel investors.

J&J in talks to buy Shockwave Medical: WSJ

Listen to the article 2 min This audio is auto-generated. Please let us know if you have feedback. Johnson & Johnson is in talks to

March 27, 2024

ZE-460134 by Eilean Therapeutics for Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia): Likelihood of Approval

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

September 14, 2023

Can a low-carb, anti-inflammatory diet be the answer to long COVID woes?

Keck Medicine of USC is conducting a clinical trial to determine if a low-carbohydrate, anti-inflammatory diet combined with a medical food raising blood ketone levels

October 10, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.